Follow
Kalijn Bol
Kalijn Bol
Radboudumc, Nijmegen, the Netherlands
Verified email at radboudumc.nl
Title
Cited by
Cited by
Year
Dendritic cell–based immunotherapy: state of the art and beyond
KF Bol, G Schreibelt, WR Gerritsen, IJM De Vries, CG Figdor
Clinical cancer research 22 (8), 1897-1906, 2016
3602016
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
JFM Jacobs, AJ Idema, KF Bol, S Nierkens, OM Grauer, P Wesseling, ...
Neuro-oncology 11 (4), 394-402, 2009
2812009
Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsMyeloid DCs Induce Effective Responses in Melanoma Patients
G Schreibelt, KF Bol, H Westdorp, F Wimmers, EHJG Aarntzen, ...
Clinical cancer research 22 (9), 2155-2166, 2016
2382016
Prognostic significance and mechanism of Treg infiltration in human brain tumors
JFM Jacobs, AJ Idema, KF Bol, JA Grotenhuis, IJM de Vries, P Wesseling, ...
Journal of neuroimmunology 225 (1-2), 195-199, 2010
2292010
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination
EHJG Aarntzen, IJM De Vries, WJ Lesterhuis, D Schuurhuis, JFM Jacobs, ...
Cancer research 73 (1), 19-29, 2013
1762013
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
KF Bol, G Schreibelt, K Rabold, SK Wculek, JK Schwarze, A Dzionek, ...
Journal for immunotherapy of cancer 7 (1), 1-13, 2019
1572019
Dendritic cell cancer therapy: vaccinating the right patient at the right time
WW Van Willigen, M Bloemendal, WR Gerritsen, G Schreibelt, ...
Frontiers in Immunology 9, 2265, 2018
1322018
Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma …
EHJG Aarntzen, G Schreibelt, K Bol, WJ Lesterhuis, AJ Croockewit, ...
Clinical Cancer Research 18 (19), 5460-5470, 2012
1252012
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
KF Bol, EHJG Aarntzen, JM Pots, MAM Olde Nordkamp, ...
Cancer Immunology, Immunotherapy 65 (3), 327-339, 2016
782016
Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
KF Bol, HW Mensink, EHJG Aarntzen, G Schreibelt, JEE Keunen, ...
American journal of ophthalmology 158 (5), 939-947. e5, 2014
772014
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
KF Bol, EHJG Aarntzen, FEM Hout, G Schreibelt, JHA Creemers, ...
Oncoimmunology 5 (1), e1057673, 2016
712016
Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell–Based Vaccination in Metastatic Melanoma
EHJG Aarntzen, K Bol, G Schreibelt, JFM Jacobs, WJ Lesterhuis, ...
Cancer research 72 (23), 6102-6110, 2012
712012
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
KF Bol, CG Figdor, EHJG Aarntzen, MEB Welzen, MM van Rossum, ...
Oncoimmunology 4 (8), e1019197, 2015
672015
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
RS Laureano, J Sprooten, I Vanmeerbeerk, DM Borras, J Govaerts, ...
Oncoimmunology 11 (1), 2096363, 2022
622022
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
S Boudewijns, M Bloemendal, N de Haas, H Westdorp, KF Bol, ...
Cancer Immunology, Immunotherapy 69, 477-488, 2020
562020
Adjuvant dendritic cell vaccination in high-risk uveal melanoma
KF Bol, T Van den Bosch, G Schreibelt, HW Mensink, JEE Keunen, E Kiliç, ...
Ophthalmology 123 (10), 2265-2267, 2016
502016
Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
KF Bol, E Ellebaek, L Hoejberg, MM Bagger, MS Larsen, TW Klausen, ...
Cancers 11 (10), 1489, 2019
462019
Naturally circulating dendritic cells to vaccinate cancer patients
KF Bol, J Tel, IJM De Vries, CG Figdor
Oncoimmunology 2 (3), e23431, 2013
422013
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell VaccinesT-cell Ratio Predicts …
A Vasaturo, A Halilovic, KF Bol, DI Verweij, WAM Blokx, CJA Punt, ...
Cancer research 76 (12), 3496-3506, 2016
412016
Human pDCs are superior to cDC2s in attracting cytolytic lymphocytes in melanoma patients receiving DC vaccination
JJP van Beek, G Flórez-Grau, MAJ Gorris, TSM Mathan, G Schreibelt, ...
Cell reports 30 (4), 1027-1038. e4, 2020
352020
The system can't perform the operation now. Try again later.
Articles 1–20